头颈部高危皮肤鳞状细胞癌:复发危险因素与辅助治疗影响
OBJECTIVES: The behavior of advanced cutaneous squamous cell carcinoma of the head and neck (HNcSCC) remains poorly understood, with highly variable risk factors and a paucity of data for adjuvant treatment.…
要点
- 肿瘤大小和神经周围侵犯是头颈部高危皮肤鳞癌复发的独立危险因素
- 辅助放疗或化放疗未显著改善2年无病生存率
- 加用化疗未显示无病生存获益,即使存在结外扩展或切缘阳性
核心结论
- 晚期头颈部皮肤鳞状细胞癌尽管接受辅助治疗,复发率仍较高。
- 肿瘤大小>2 cm是复发的强独立危险因素。
- 神经周围侵犯是与无病生存期恶化最相关的传统黏膜头颈鳞癌危险因素。
- 加用化疗未观察到生存获益。
研究设计与样本
- 中位年龄68岁(范围42-91岁)。
- 21例接受单纯手术,45例接受辅助放疗,38例接受辅助化放疗。
关键数值与推荐
- 肿瘤大小>2 cm是复发的强独立危险因素。
- 神经周围侵犯与更差的无病生存期强烈相关。
- 辅助化疗未显示无病生存获益。
临床怎么用
- 对于头颈部高危皮肤鳞状细胞癌,应关注肿瘤大小和神经周围侵犯以评估复发风险。
- 辅助放疗或化放疗的选择需权衡获益,化疗的加用未显示生存优势。
局限性
- 回顾性研究设计。
- 证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The behavior of advanced cutaneous squamous cell carcinoma of the head and neck (HNcSCC) remains poorly understood, with highly variable risk factors and a paucity of data for adjuvant treatment. The objective of our study was to review the oncologic outcomes of patients with high-risk HNcSCC treated with surgery and to identify risk factors for treatment failure. STUDY DESIGN: Retrospective cohort study. METHODS: Retrospective review of patients treated for HNcSCC with definitive surgery involving at least parotidectomy and neck dissection at a tertiary care academic center from 2011 to 2017 was conducted. The primary outcome was disease-free survival (DFS). RESULTS: One-hundred four patients with a median age of 68 years (range = 42-91 years) were reviewed. Twenty-one patients were treated with surgery alone, 45 patients underwent adjuvant radiotherapy (RT), and 38 patients underwent adjuvant chemoradiotherapy (CRT). The 2-year DFS for patients treated with surgery, surgery + RT, and surgery + CRT were 71%, 65%, and 58%, respectively, with no significant difference between the groups (P = .70). On multivariate analyses, tumor size (P = .006) and perineural invasion (PNI, P = .04) independently predicted recurrence. The addition of chemotherapy did not appear to improve DFS, neither for those patients with extranodal extension and/or positive margins (P = .93) nor for the entire cohort (P = .43). CONCLUSIONS: Advanced HNcSCC has a high recurrence rate despite adjuvant treatment. Tumor size >2 cm was a strong independent risk factor for recurrence. Out of the traditional mucosal HNcSCC risk factors, PNI was most strongly associated with worse DFS. There was no observed survival benefit to the addition of chemotherapy. LEVEL OF EVIDENCE: 4. Laryngoscope, 131:E136-E143, 2021.
引用
- Trosman SJ, Zhu A, Nicolli EA, et al. High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: Risk Factors for Recurrence and Impact of Adjuvant Treatment. Laryngoscope. 2020. PMID: 32065413. doi:10.1002/lary.28564
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。